Literature DB >> 29679570

HMGB1-containing nucleosome mediates chemotherapy-induced metastasis of human lung cancer.

Kailing Wang1, Shan Shan2, Shenqi Wang2, Xiaohua Gu2, Xiaohui Zhou3, Tao Ren4.   

Abstract

While chemotherapy is an important and widely used therapeutic for cancer, it may facilitate cancer metastasis. Herein, we report that human lung cancer cells exert higher invasion and metastasis after chemotherapy. In a human lung cancer xenograft model, chemotherapy promotes the cancer invasion and metastasis in HMGB1-dependent manner. Further studies identify HMGB1-containing nucleosome from chemotherapy-induced apoptotic cancer cells as an effective factor. Such nucleosome functions through TLR4 and TLR9 to drive cancer invasion and metastasis. In lung cancer patients, circulating HMGB1-containing nucleosome is higher in those under chemotherapy, predicting poorly cancer cell differentiation state, enhanced cancer invasion and advanced TNM stages. These findings provide a novel mechanism by which the tumor metastasis is propagated in lung cancer patients, especially in those under chemotherapy, and a clue for developing therapeutic strategies against chemotherapy-induced metastasis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; HMGB1; Lung cancer; Nucleosome

Mesh:

Substances:

Year:  2018        PMID: 29679570     DOI: 10.1016/j.bbrc.2018.04.150

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  The Influence of Proteins on Fate and Biological Role of Circulating DNA.

Authors:  Oleg Tutanov; Svetlana Tamkovich
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

2.  Downregulation of high mobility group box 1 enhances the radiosensitivity of non-small cell lung cancer by acting as a crucial target of microRNA-107.

Authors:  Lu Bai; Jingjing Zhang; Dongqi Gao; Chengyi Liu; Wenxin Li; Qingshan Li
Journal:  Exp Ther Med       Date:  2021-04-25       Impact factor: 2.447

3.  Mechanisms of Compound Kushen Injection for the Treatment of Lung Cancer Based on Network Pharmacology.

Authors:  Ziqi Meng; Xinkui Liu; Jiarui Wu; Wei Zhou; Kaihuan Wang; Zhiwei Jing; Shuyu Liu; Mengwei Ni; Xiaomeng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-28       Impact factor: 2.629

4.  miR-142-3p reduces the viability of human cervical cancer cells by negatively regulating the cytoplasmic localization of HMGB1.

Authors:  Hui Dong; Jie Song
Journal:  Exp Ther Med       Date:  2021-01-14       Impact factor: 2.447

Review 5.  Nuclear Alarmin Cytokines in Inflammation.

Authors:  Lili Jiang; Yijia Shao; Yao Tian; Changsheng Ouyang; Xiaohua Wang
Journal:  J Immunol Res       Date:  2020-12-04       Impact factor: 4.818

6.  Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs.

Authors:  H M Wilson-Robles; T Bygott; T K Kelly; T M Miller; P Miller; M Matsushita; J Terrell; M Bougoussa; T Butera
Journal:  BMC Vet Res       Date:  2022-08-31       Impact factor: 2.792

Review 7.  Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1.

Authors:  Carolina M Gorgulho; Graziela G Romagnoli; Rosh Bharthi; Michael T Lotze
Journal:  Front Immunol       Date:  2019-07-11       Impact factor: 7.561

8.  Plasma Nucleosomes in Primary Breast Cancer.

Authors:  Michal Mego; Katarina Kalavska; Marian Karaba; Gabriel Minarik; Juraj Benca; Tatiana Sedlackova; Paulina Gronesova; Dana Cholujova; Daniel Pindak; Jozef Mardiak; Peter Celec
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

9.  Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis.

Authors:  Chao-Qun Wang; Bi-Fei Huang; Yan Wang; Chih-Hsin Tang; Hong-Chuan Jin; Feng Shao; Jun-Kang Shao; Qian Wang; Yue Zeng
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.